Anticoagulation Reversal and Treatment Strategies in Major Bleeding: Update 2016

被引：31
作者：
Christos, Steve [1 ]
Naples, Robin [2 ]
机构：
[1] Presence Resurrect Med Ctr, Dept Emergency Med, 7435 West Talcott, Chicago, IL 60631 USA
[2] Temple Univ, Dept Emergency Med, Lewis Katz Sch Med, Philadelphia, PA 19122 USA
来源：
WESTERN JOURNAL OF EMERGENCY MEDICINE | 2016年 / 17卷 / 03期
关键词：
D O I：
10.5811/westjem.2016.3.29294
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：264 / 270
页数：7
相关论文
共 17 条
[1]   Direct Oral Anticoagulants (DOACs) in the Laboratory: 2015 Review [J].
Adcock, D. M. ;
Gosselin, R. .
THROMBOSIS RESEARCH, 2015, 136 (01) :7-12
[2]   Who, when, and how to reverse non-vitamin K oral anticoagulants [J].
Aronis, Konstantinos N. ;
Hylek, Elaine M. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 41 (02) :253-272
[3]   Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate A Randomized, Placebo-Controlled, Crossover Study in Healthy Subjects [J].
Eerenberg, Elise S. ;
Kamphuisen, Pieter W. ;
Sijpkens, Meertien K. ;
Meijers, Joost C. ;
Buller, Harry R. ;
Levi, Marcel .
CIRCULATION, 2011, 124 (14) :1573-1579
[4]   THE CLINICAL USE OF PROTHROMBIN COMPLEX CONCENTRATE [J].
Ferreira, Jason ;
DeLosSantos, Marci .
JOURNAL OF EMERGENCY MEDICINE, 2013, 44 (06) :1201-1210
[5]   Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial [J].
Glund, Stephan ;
Stangier, Joachim ;
Schmohl, Michael ;
Gansser, Dietmar ;
Norris, Stephen ;
van Ryn, Joanne ;
Lang, Benjamin ;
Ramael, Steven ;
Moschetti, Viktoria ;
Gruenenfelder, Fredrik ;
Reilly, Paul ;
Kreuzer, Joerg .
LANCET, 2015, 386 (9994) :680-690
[6]   Anticoagulation Drug Therapy: A Review [J].
Harter, Katherine ;
Levine, Michael ;
Henderson, Sean O. .
WESTERN JOURNAL OF EMERGENCY MEDICINE, 2015, 16 (01) :11-17
[7]   Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report [J].
Kearon, Clive ;
Akl, Elie A. ;
Ornelas, Joseph ;
Blaivas, Allen ;
Jimenez, David ;
Bounameaux, Henri ;
Huisman, Menno ;
King, Christopher S. ;
Morris, Timothy A. ;
Sood, Namita ;
Stevens, Scott M. ;
Vintch, Janine R. E. ;
Wells, Philip ;
Woller, Scott C. ;
Moores, Lisa .
CHEST, 2016, 149 (02) :315-352
[8]   Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications [J].
Lazo-Langner, Alejandro ;
Lang, Eddy S. ;
Douketis, James .
CRITICAL CARE, 2013, 17 (03)
[9]   Reversal of New, Factor-specific Oral Anticoagulants by rFVIIa, Prothrombin Complex Concentrate and Activated Prothrombin Complex Concentrate: A Review of Animal and Human Studies [J].
Lee, Frank M. H. ;
Chan, Anthony K. C. ;
Lau, Keith K. ;
Chan, Howard H. .
THROMBOSIS RESEARCH, 2014, 133 (05) :705-713
[10]   Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays [J].
Lindahl, Tomas L. ;
Baghaei, Fariba ;
Blixter, Inger Fagerberg ;
Gustafsson, Kerstin M. ;
Stigendal, Lennart ;
Sten-Linder, Margareta ;
Strandberg, Karin ;
Hillarp, Andreas .
THROMBOSIS AND HAEMOSTASIS, 2011, 105 (02) :371-378
12